OFFIDANI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 224
EU - Europa 150
AS - Asia 80
AF - Africa 25
SA - Sud America 4
Totale 483
Nazione #
US - Stati Uniti d'America 224
IT - Italia 58
CN - Cina 41
IE - Irlanda 19
SE - Svezia 19
SG - Singapore 19
CI - Costa d'Avorio 17
UA - Ucraina 15
FR - Francia 11
GB - Regno Unito 9
TR - Turchia 9
DE - Germania 8
DK - Danimarca 6
MA - Marocco 6
FI - Finlandia 4
IN - India 4
JP - Giappone 4
KR - Corea 3
BR - Brasile 2
PE - Perù 2
SN - Senegal 2
NL - Olanda 1
Totale 483
Città #
Boardman 38
Chandler 26
Dublin 19
Abidjan 17
Ashburn 15
Jacksonville 15
Fairfield 14
Wilmington 11
New York 10
Singapore 9
Guangzhou 7
Seattle 7
Turin 6
Woodbridge 6
Cambridge 5
Falconara Marittima 5
Houston 5
Lawrence 5
Princeton 5
Milan 4
Washington 4
Ann Arbor 3
Los Angeles 3
San Mateo 3
Santa Clara 3
Shenzhen 3
Southwark 3
Wuxi 3
Altamura 2
Beijing 2
Brescia 2
Centro 2
Corridonia 2
Dakar 2
Florence 2
Foggia 2
Guiyang 2
Jiaxing 2
Kilburn 2
Lima 2
Munich 2
Nanjing 2
Rome 2
San Benedetto del Tronto 2
Secaucus 2
São Paulo 2
Vasco da Gama 2
Visakhapatnam 2
Xi'an 2
Yiwu 2
Ancona 1
Clifton 1
Fayetteville 1
Foshan 1
Helsinki 1
Hounslow 1
Islington 1
Izmir 1
Jinan 1
Jinhua 1
Kagoya 1
Lanciano 1
Nanning 1
Oakland 1
Osimo 1
Pescara 1
Porto 1
San Diego 1
Weehawken 1
Wuhan 1
Totale 318
Nome #
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 93
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 75
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 61
Real‐world assessment of treatment patterns and outcomes in patients with relapsed‐refractory multiple myeloma in an Italian haematological tertiary care centre 39
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 37
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 35
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis 32
Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases 28
Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety 26
Current Main Topics in Multiple Myeloma 21
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report 14
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment 13
Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences 12
null 11
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy 10
The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management 9
Sequential Bispecific Antibodies in Functional and Clinical High Risk Multiple Myeloma, Manifesting with Extramedullary Disease at Relapse: A Case Report 7
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 4
Totale 527
Categoria #
all - tutte 3.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 3 0 3 0 3 0 1 3
2020/202144 4 3 8 0 3 1 5 2 6 3 6 3
2021/202232 2 3 2 1 0 1 5 3 1 2 6 6
2022/202387 5 11 7 3 4 11 0 4 18 0 24 0
2023/2024182 15 5 8 11 22 18 4 5 9 7 23 55
2024/2025107 43 28 21 6 9 0 0 0 0 0 0 0
Totale 527